羟钴胺在左心室辅助装置患者血管麻痹综合征中的应用。

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients.

作者信息

Ayers Brian, Wood Katherine, Falvey Jennifer, Bernstein Wendy, Gosev Igor

机构信息

Division of Cardiac Surgery University of Rochester Medical Center Rochester NY USA.

Farmacy University of Rochester Medical Center Rochester NY USA.

出版信息

Clin Case Rep. 2020 Jun 26;8(9):1722-1727. doi: 10.1002/ccr3.2967. eCollection 2020 Sep.

DOI:10.1002/ccr3.2967

PMID:32983485

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7495745/

Abstract

We demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice.

摘要

我们证明了支持羟钴胺素对左心室辅助装置（LVAD）难治性血管麻痹患者降低血管升压药需求有效性的证据。需要进一步研究来证实这些发现并确定其在实际应用中的最佳用法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b16/7495745/7f36b829c411/CCR3-8-1722-g001.jpg

相似文献

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients.

Clin Case Rep. 2020 Jun 26;8(9):1722-1727. doi: 10.1002/ccr3.2967. eCollection 2020 Sep.

Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.

Am J Case Rep. 2021 Jun 18;22:e930890. doi: 10.12659/AJCR.930890.

High-Dose Hydroxocobalamin for Refractory Vasoplegia Post Cardiac Surgery.

Cureus. 2022 Aug 22;14(8):e28267. doi: 10.7759/cureus.28267. eCollection 2022 Aug.

Use of hydroxocobalamin to treat intraoperative vasoplegic syndrome refractory to vasopressors and methylene blue during liver transplantation.

Clin Transplant. 2024 Mar;38(3):e15271. doi: 10.1111/ctr.15271.

Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.

J Cardiothorac Vasc Anesth. 2019 May;33(5):1301-1307. doi: 10.1053/j.jvca.2018.11.020. Epub 2018 Nov 16.

Vasoplegia from Continuous Flow Left Ventricular Assist Devices.

Curr Cardiol Rep. 2021 Jul 1;23(8):101. doi: 10.1007/s11886-021-01534-y.

Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series.

Can J Anaesth. 2018 May;65(5):560-568. doi: 10.1007/s12630-017-1029-3. Epub 2017 Dec 5.

The use of high-dose hydroxocobalamin for vasoplegic syndrome.

Ann Thorac Surg. 2014 May;97(5):1785-6. doi: 10.1016/j.athoracsur.2013.08.050.

Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report.

Transplant Proc. 2021 May;53(4):1300-1302. doi: 10.1016/j.transproceed.2020.09.019. Epub 2020 Nov 24.

Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.

J Card Surg. 2021 Oct;36(10):3749-3760. doi: 10.1111/jocs.15805. Epub 2021 Jul 12.

引用本文的文献

Prognostic value of the vasoactive-inotropic score in predicting outcomes following LVAD implantation.

JHLT Open. 2025 Apr 24;9:100272. doi: 10.1016/j.jhlto.2025.100272. eCollection 2025 Aug.

本文引用的文献

Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.

Crit Care. 2020 Feb 4;24(1):36. doi: 10.1186/s13054-020-2743-8.

Hydroxocobalamin treatment of refractory vasoplegia in patients with mechanical circulatory support.

J Heart Lung Transplant. 2019 Apr;38(4):467-469. doi: 10.1016/j.healun.2019.01.003. Epub 2019 Jan 7.

Development and performance of a novel vasopressor-driven mortality prediction model in septic shock.

Ann Intensive Care. 2018 Nov 22;8(1):112. doi: 10.1186/s13613-018-0459-6.

Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use.

J Cardiothorac Vasc Anesth. 2019 Apr;33(4):894-901. doi: 10.1053/j.jvca.2018.08.017. Epub 2018 Aug 11.

Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.

J Cardiothorac Vasc Anesth. 2018 Apr;32(2):1013-1022. doi: 10.1053/j.jvca.2017.10.032. Epub 2017 Oct 27.

The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.

Ann Card Anaesth. 2017 Oct-Dec;20(4):462-464. doi: 10.4103/aca.ACA_88_17.

Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases.

J Cardiothorac Vasc Anesth. 2018 Feb;32(1):452-457. doi: 10.1053/j.jvca.2017.04.002. Epub 2017 Apr 5.

High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm.

Clin Kidney J. 2017 Jun;10(3):357-362. doi: 10.1093/ckj/sfx004. Epub 2017 Mar 15.

Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.

Ann Thorac Surg. 2017 Jul;104(1):36-41. doi: 10.1016/j.athoracsur.2017.02.057. Epub 2017 May 24.

Treatment of Vasoplegic Syndrome With Intravenous Hydroxocobalamin During Liver Transplantation.

J Cardiothorac Vasc Anesth. 2017 Aug;31(4):1381-1384. doi: 10.1053/j.jvca.2016.10.011. Epub 2016 Oct 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

羟钴胺在左心室辅助装置患者血管麻痹综合征中的应用。

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

羟钴胺在左心室辅助装置患者血管麻痹综合征中的应用。

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献